Suppr超能文献

随机经冠状窦输注 CD34(+) 细胞联合灌注与停流方法治疗近期心肌梗死患者:早期心脏对 ⁹⁹(m)Tc 标记细胞活性的保留。

Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of ⁹⁹(m)Tc-labeled cells activity.

机构信息

Department of Cardiac and Vascular Diseases, John Paul II Hospital, Institute of Cardiology, Jagiellonian University, Krakow, Poland.

出版信息

J Nucl Cardiol. 2011 Feb;18(1):104-16. doi: 10.1007/s12350-010-9326-z. Epub 2010 Dec 14.

Abstract

BACKGROUND

For transcoronary progenitor cells' administration, injections under flow arrest (over-the-wire balloon technique, OTW) are used universally despite lack of evidence for being required for cell delivery or being effective in stimulating myocardial engraftment. Flow-mediated endothelial rolling is mandatory for subsequent cell adhesion and extravasation.

METHODS

To optimize cell directing toward the coronary endothelium under maintained flow, the authors developed a cell-delivery side-holed perfusion catheter (PC). Thirty-four patients (36-69 years, 30 men) with primary stent-assisted angioplasty-treated anterior MI (peak TnI 151 [53-356]ng/dL, mean[range]) were randomly assigned to OTW or PC autologous ⁹⁹Tc-extametazime-labeled bone marrow CD34(+) cells (4.34 [0.92-7.54] × 10⁶) administration at 6-14 days after pPCI (LVEF 37.1 [24-44]%). Myocardial perfusion (⁹⁹(m)Tc-MIBI) and labeled cells' activity were evaluated (SPECT) at, respectively, 36-48 h prior to and 60 min after delivery.

RESULTS

In contrast to OTW coronary occlusions, no intolerance or ventricular arrhythmia occurred with PC cells' administration (P < .001). One hour after delivery, 4.86 [1.7-7.6]% and 5.05 [2.2-9.9]% activity was detected in the myocardium (OTW and PC, respectively, P = .84). Labeled cell activity was clearly limited to the (viable) peri-infarct zone in 88% patients, indicating that the infarct core zone may be largely inaccessible to transcoronary-administered cells.

CONCLUSIONS

Irrespective of the transcoronary delivery method, only ≈ 5% of native (i.e., non-engineered) CD34(+) cells spontaneously home to the injured myocardium, and cell retention occurs preferentially in the viable peri-infarct zone. Although the efficacy of cell delivery is not increased with the perfusion method, by avoiding provoking ischemic episodes PC offers a rational alternative to the OTW delivery.

摘要

背景

尽管缺乏证据表明其对于细胞输送或刺激心肌植入是必需的,但是对于经冠状窦祖细胞的给药,仍普遍采用在血流停止时的注射(经导丝球囊技术,OTW)。血流介导的内皮细胞滚动对于随后的细胞黏附和渗出是必需的。

方法

为了在维持血流的情况下优化细胞向冠状动脉内皮的定向,作者开发了一种细胞输送侧孔灌注导管(PC)。34 名患者(36-69 岁,30 名男性)接受了原发性支架辅助血管成形术治疗前壁心肌梗死(峰值肌钙蛋白 I 151 [53-356]ng/dL,平均[范围]),随机分为 OTW 或 PC 组,给予自体 99Tc-甲氧基异丁基异腈标记的骨髓 CD34(+)细胞(4.34 [0.92-7.54]×106),在 pPCI 后 6-14 天(LVEF 37.1 [24-44]%)。在给药前 36-48 小时和给药后 60 分钟,分别用 99mTc-MIBI 心肌灌注和标记细胞活性进行评估(SPECT)。

结果

与 OTW 冠状动脉闭塞不同,PC 细胞给药未发生不耐受或室性心律失常(P<0.001)。给药后 1 小时,心肌内分别检测到 4.86 [1.7-7.6]%和 5.05 [2.2-9.9]%的活性(OTW 和 PC,分别,P=0.84)。标记细胞活性在 88%的患者中明确局限于(存活的)梗死周边区,表明梗死核心区可能很大程度上无法被经冠状窦给予的细胞到达。

结论

无论采用何种经冠状窦的输送方法,仅有约 5%的天然(即未经工程化)CD34(+)细胞自发归巢到受损的心肌,并且细胞保留主要发生在存活的梗死周边区。尽管细胞输送的疗效并未通过该灌注方法增加,但通过避免引起缺血发作,PC 为 OTW 输送提供了一种合理的替代方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/745d/3032199/c0800fa21716/12350_2010_9326_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验